Policy & Regulation

Value-based drug pricing coming soon in UK

Friday 5 April 2013

Interviewee/Contributer: Karen Fi nn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Managers ignore pharmacovigilance at their peril

Wednesday 16 January 2013

Interviewee/Contributer: Johan Strömquist

Organisation: NDA Group

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Adaptive licensing: A new approach for drug approvals

Tuesday 15 January 2013

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

IMI: As Big Pharma pulls back, IMI steps in

Saturday 1 December 2012

Interviewee/Contributer: Michel Goldman

Organisation: Innovative Medicines Initiative

Full text available to subscribers only. Click here for information on subscribing to MedNous.

MRC Technology: Going global for local returns

Friday 30 November 2012

Interviewee/Contributer: Dave Tapolczay

Organisation: MRC Technology

Full text available to subscribers only. Click here for information on subscribing to MedNous.

EU Transparency Directive: changes afoot on pricing and reimbursement

Thursday 29 November 2012

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How to strengthen the biopharma ecosystem

Tuesday 27 November 2012

Interviewee/Contributer: Roberto Gradnik

Organisation: European Biopharmaceutical Enterprises

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Planning for the Unified Patent Court

Friday 20 July 2012

Interviewee/Contributer: Kevin Mooney

Organisation: Simmons & Simmons LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

An analysis of accelerated approval for cancer drugs

Wednesday 18 July 2012

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Avastin vs Lucentis: the drug reimbursement dilemma of the century

Thursday 14 June 2012

Interviewee/Contributer: Karen Finn

Organisation: Mednous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content